Two stocks that Osho Krishan of Anand Rathi is bullish on



BUY ROSSARI BIOTECH LTD | TARGET: Rs 1,560 | STOP LOSS: Rs 1,360


ROSSARI BIOTECH has been in a secular uptrend and is placed well above all the major exponential moving averages on the daily charts, suggesting inherent strength in the stock. Alongside, it formed a strong bullish candle in the last trading session on the back of an increase in average traded volumes, affirming the bullish stance. On the oscillator front, 14 period RSI has been trading in higher region post positive crossover assuring the strength in the up move and the stock seems to test the uncharted territory.





BUY STRIDES PHARMA SCIENCE LTD | TARGET: Rs 660 | STOP LOSS: Rs 580


STRIDES PHARMA SCIENCE has seen a massive correction in recent times and is currently is hovering near the 50% Fibonacci retracement of the rally. However, last week, the counter had formed a ‘hammer’ candlestick pattern, indicating the initial sign of trend reversal. Further, the 14 period RSI reversed its trend from the oversold region and has gradually started to surge post positive crossover, affirming strengthening demand zone at lower levels.


===================================================


Osho Krishan is senior manager – Equity Research at Shares & Stock Brokers. Views are personal.

Dear Reader,

Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.

We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor





Source link

Share Market Today
Logo